mTOR and its signaling pathway in gastric cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 930-933, 2010.
Artículo
en Chino
| WPRIM
| ID: wpr-385603
ABSTRACT
Mammalian target of rapamycin (mTOR) and its signaling pathway regulate protein synthesis, cell growth and metabolism, and angiogenesis. This pathway is highly activated in gastric cancer and closely related to the progression and prognosis of the cancer. Blocking the mTOR signaling pathway by rapamycin and its derivatives can inhibit gastric cancer cell growth and promote tumor necrosis and such effects can be synergistically improved by combined use of other chemotherapeutic agents. Thus, rapamycin and its derivatives may be effective in the prevention and treatment of gastric cancer.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of International Oncology
Año:
2010
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS